Guardant Health (GH) Non-Current Deffered Revenue (2017 - 2019)

Guardant Health has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $10.6 million for Q3 2019.

• In Q3 2019, Non-Current Deffered Revenue rose 38.58% year-over-year to $10.6 million; the TTM figure through Sep 2019 stood at $10.6 million (up 38.58% YoY), while the FY2018 annual figure was $7.8 million, up 19.99% from the prior year.
• Non-Current Deffered Revenue came in at $10.6 million for Q3 2019 at Guardant Health, down from $10.9 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $10.9 million in Q2 2019 to a low of $6.5 million in Q4 2017.
• Average Non-Current Deffered Revenue over 3 years is $8.7 million, with a median of $8.4 million recorded in 2018.
• Year-over-year, Non-Current Deffered Revenue gained 19.99% in 2018 and soared 38.58% in 2019.
• Over 3 years, Non-Current Deffered Revenue stood at $6.5 million in 2017, then grew by 19.99% to $7.8 million in 2018, then surged by 34.68% to $10.6 million in 2019.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $10.6 million in Q3 2019, $10.9 million in Q2 2019, and $9.0 million in Q1 2019.